Advantage Alpha Capital Partners LP Ani Pharmaceuticals Inc Transaction History
Advantage Alpha Capital Partners LP
- $361 Million
- Q1 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 10,199 shares of ANIP stock, worth $688,228. This represents 0.19% of its overall portfolio holdings.
Number of Shares
10,199
Previous 27
37674.07%
Holding current value
$688,228
Previous $1,000
68100.0%
% of portfolio
0.19%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANIP
# of Institutions
238Shares Held
19.9MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$179 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$79.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$55.2 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$49.6 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$48.8 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.18B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...